Dah Sing Pharma surged over 24% in Hong Kong Stock Market, up over 45% in the past 5 days, with a market cap rising to HKD 4.761 billion

On December 31, market data shows Hong Kong-listed Delin Holdings surged more than 24%—and over 45% in the past five trading days—pushing its market capitalization to HK$4.761 billion. In related news, Delin Holdings said its 70%-owned subsidiary Delin Securities (Hong Kong) Limited received conditional approval on December 29, 2025, from the Hong Kong Securities and Futures Commission (SFC) to offer virtual asset trading services via a comprehensive account arrangement. The approval is subject to the subsidiary meeting specific conditions for its existing Type 1 (securities trading) regulated activities license to become effective. As previously reported by BlockBeats, Delin Holdings on October 21 announced it had signed a placement and subscription agreement targeting approximately HK$973 million in proceeds. The deal involves placing 255 million shares, with 63.8 million shares issued to Evergreen Wealth Investment Limited at a placement price of HK$3.05 per share—representing an ~11.34% discount to the prior day’s closing price. The funds will be allocated as follows: 56% to Bitcoin mining expansion, 24% to developing gold-backed real-world asset (RWA) tokenization products, 10% to strategic investments, and 10% to working capital.